Variant report

Variant	rs181715293
Chromosome Location	chr7:27170833-27170834
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	PML	chr7:27170241-27171078	MCF-7	breast:	n/a	n/a
2	POLR2A	chr7:27170471-27170937	Hela-S3	cervix:	n/a	n/a
3	ELF1	chr7:27170248-27171167	MCF-7	breast:	n/a	n/a
4	E2F6	chr7:27170400-27171127	H1-hESC	embryonic stem cell:	n/a	n/a
5	TAF1	chr7:27169551-27170999	HepG2	liver:	n/a	n/a
6	E2F6	chr7:27170359-27171047	H1-hESC	embryonic stem cell:	n/a	n/a
7	MAX	chr7:27170259-27171131	NB4	blood:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
8	BHLHE40	chr7:27170273-27170880	HepG2	liver:	n/a	n/a
9	USF1	chr7:27170300-27171154	HCT-116	colon:	n/a	n/a
10	POLR2A	chr7:27170388-27170925	HepG2	liver:	n/a	n/a
11	POLR2A	chr7:27169922-27171303	MCF10A-Er-Src	breast:	n/a	n/a
12	ZNF143	chr7:27170308-27171004	H1-hESC	embryonic stem cell:	n/a	chr7:27170536-27170554 chr7:27170576-27170586
13	MYC	chr7:27170744-27170860	MCF-7	breast:	n/a	n/a
14	USF1	chr7:27170215-27171037	HCT-116	colon:	n/a	n/a
15	SP1	chr7:27170160-27170913	A549	lung:	n/a	chr7:27170671-27170685 chr7:27170554-27170566 chr7:27170555-27170564 chr7:27170693-27170707 chr7:27170555-27170564 chr7:27170556-27170565 chr7:27170464-27170475 chr7:27170665-27170679 chr7:27170415-27170426 chr7:27170554-27170566 chr7:27170555-27170569
16	MAX	chr7:27170213-27171081	H1-hESC	embryonic stem cell:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
17	ELF1	chr7:27170201-27171108	HCT-116	colon:	n/a	n/a
18	TBP	chr7:27170592-27170850	HepG2	liver:	n/a	n/a
19	HA-E2F1	chr7:27169989-27171216	MCF-7	breast:	n/a	n/a
20	YY1	chr7:27169663-27170913	HepG2	liver:	n/a	chr7:27170691-27170702
21	POLR2A	chr7:27170407-27170913	ECC-1	luminal epithelium:	n/a	n/a
22	POLR2A	chr7:27169633-27171106	MCF-7	breast:	n/a	n/a
23	HEY1	chr7:27169626-27170942	HepG2	liver:	n/a	chr7:27170546-27170561
24	ELF1	chr7:27170468-27170873	SK-N-SH	brain:	n/a	n/a
25	POLR2A	chr7:27170478-27170850	A549	lung:	n/a	n/a
26	POLR2A	chr7:27170229-27171001	U87	brain:	n/a	n/a
27	SP1	chr7:27170201-27170883	H1-hESC	embryonic stem cell:	n/a	chr7:27170671-27170685 chr7:27170554-27170566 chr7:27170555-27170564 chr7:27170693-27170707 chr7:27170555-27170564 chr7:27170556-27170565 chr7:27170464-27170475 chr7:27170665-27170679 chr7:27170415-27170426 chr7:27170554-27170566 chr7:27170555-27170569
28	MAZ	chr7:27169186-27171474	IMR90	lung:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
29	E2F4	chr7:27170351-27170907	MCF10A-Er-Src	breast:	n/a	n/a
30	CREB1	chr7:27170419-27170834	A549	lung:	n/a	n/a
31	MYC	chr7:27170358-27170937	MCF-7	breast:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
32	CHD2	chr7:27170224-27170858	HepG2	liver:	n/a	chr7:27170554-27170564
33	POLR2A	chr7:27169123-27171548	HepG2	liver:	n/a	n/a
34	MXI1	chr7:27170533-27171058	H1-hESC	embryonic stem cell:	n/a	n/a
35	USF1	chr7:27170271-27170937	SK-N-SH	brain:	n/a	n/a
36	MAX	chr7:27170419-27170933	H1-hESC	embryonic stem cell:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
37	POLR2A	chr7:27170455-27170856	A549	lung:	n/a	n/a
38	TAF1	chr7:27170395-27170921	A549	lung:	n/a	n/a
39	MAX	chr7:27170331-27171109	A549	lung:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
40	GABPA	chr7:27170327-27171078	MCF-7	breast:	n/a	chr7:27170602-27170611 chr7:27170600-27170609
41	MAX	chr7:27170203-27171235	A549	lung:	n/a	chr7:27170570-27170577 chr7:27170567-27170576
42	POLR2A	chr7:27170349-27171084	HL-60	blood:	n/a	n/a
43	ZNF263	chr7:27170351-27171165	HEK293-T-REx	kidney:	n/a	chr7:27170533-27170542
44	POLR2A	chr7:27170223-27171018	U87	brain:	n/a	n/a
45	USF1	chr7:27170302-27170887	H1-hESC	embryonic stem cell:	n/a	n/a
46	TEAD4	chr7:27170680-27170960	H1-hESC	embryonic stem cell:	n/a	n/a
47	ELF1	chr7:27170359-27170862	GM12878	blood:	n/a	n/a
48	POLR2A	chr7:27170425-27170904	A549	lung:	n/a	n/a
49	TCF12	chr7:27170177-27171016	A549	lung:	n/a	n/a
50	TAF1	chr7:27170433-27170922	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:27170832-27170882	MCF10A-Er-Src	breast:	n/a
2	chr7:27170819-27170869	HL-60	blood:	n/a
3	chr7:27170819-27170869	HPAEpiC	pulmonary alveolar:	n/a
4	chr7:27170832-27170882	NHBE	bronchial:	n/a
5	chr7:27170819-27170869	RPTEC	kidney:	n/a
6	chr7:27170832-27170882	NH-A	brain:	n/a
7	chr7:27170832-27170882	H1-hESC	embryonic stem cell:	embryo
8	chr7:27170832-27170882	GM06990	blood:	n/a
9	chr7:27170819-27170869	AoSMC	blood vessel:	n/a
10	chr7:27170819-27170869	T-47D	breast:	n/a
11	chr7:27170832-27170882	HRE	kidney:	n/a
12	chr7:27170832-27170882	AoSMC	blood vessel:	n/a
13	chr7:27170832-27170882	CMK	blood:	n/a
14	chr7:27170819-27170869	BE2_C	brain:	n/a
15	chr7:27170819-27170869	K562	blood:	n/a
16	chr7:27170832-27170882	U87	brain:	n/a
17	chr7:27170832-27170882	HAEpiC	amniotic membrane:	n/a
18	chr7:27170832-27170882	HCT-116	colon:	n/a
19	chr7:27170819-27170869	GM12892	blood:	n/a
20	chr7:27170832-27170882	MCF-7	breast:	n/a
21	chr7:27170819-27170869	MCF-7	breast:	n/a
22	chr7:27170819-27170869	NHBE	bronchial:	n/a
23	chr7:27170819-27170869	ovcar-3	ovarian:	n/a
24	chr7:27170819-27170869	Hepatocyte	liver:	n/a
25	chr7:27170819-27170869	Caco-2	colon:	n/a
26	chr7:27170819-27170869	HNPCEpiC	eye:	n/a
27	chr7:27170819-27170869	Jurkat	blood:	n/a
28	chr7:27170832-27170882	BE2_C	brain:	n/a
29	chr7:27170832-27170882	GM12892	blood:	n/a
30	chr7:27170819-27170869	HRPEpiC	eye:	n/a
31	chr7:27170832-27170882	SK-N-SH	brain:	n/a
32	chr7:27170832-27170882	AG04449	skin:	fetal
33	chr7:27170832-27170882	Jurkat	blood:	n/a
34	chr7:27170819-27170869	GM19239	blood:	n/a
35	chr7:27170832-27170882	HEK293	kidney:	embryo
36	chr7:27170832-27170882	IMR90	lung:	fetal
37	chr7:27170819-27170869	PrEC	prostate:	n/a
38	chr7:27170819-27170869	HEEpiC	esophagus:	n/a
39	chr7:27170819-27170869	NT2-D1	testis:	n/a
40	chr7:27170832-27170882	Caco-2	colon:	n/a
41	chr7:27170819-27170869	BJ	skin:	n/a
42	chr7:27170832-27170882	GM12891	blood:	n/a
43	chr7:27170819-27170869	U87	brain:	n/a
44	chr7:27170832-27170882	RPTEC	kidney:	n/a
45	chr7:27170832-27170882	NT2-D1	testis:	n/a
46	chr7:27170832-27170882	NHDF-neo	bronchial:	n/a
47	chr7:27170819-27170869	CMK	blood:	n/a
48	chr7:27170832-27170882	PrEC	prostate:	n/a
49	chr7:27170819-27170869	AG10803	skin:	n/a
50	chr7:27170819-27170869	HCT-116	colon:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:26902547..26905705-chr7:27166224..27172586,14	MCF-7	breast:
2	chr7:27154191..27156761-chr7:27169805..27172339,2	MCF-7	breast:
3	chr7:27163696..27168800-chr7:27169622..27172644,4	K562	blood:
4	chr7:27164893..27167743-chr7:27169622..27171494,2	K562	blood:
5	chr14:55517858..55520148-chr7:27170683..27172278,2	MCF-7	breast:
6	chr7:27169441..27172151-chr7:27190133..27191991,3	MCF-7	breast:
7	chr7:27170268..27172208-chr7:27181167..27182998,2	MCF-7	breast:
8	chr7:27161653..27164579-chr7:27169154..27171048,2	MCF-7	breast:
9	chr7:26894678..26896550-chr7:27170054..27174548,4	MCF-7	breast:
10	chr7:26897524..26906359-chr7:27169396..27177834,18	MCF-7	breast:
11	chr7:26903161..26904431-chr7:27170079..27171250,4	MCF-7	breast:

Variant related genes	Relation type
HOXA3	TF binding region
HOXA4	TF binding region
HOXA4	CpG island
HOXA3	CpG island
ENSG00000253552	Chromatin interaction
ENSG00000005020	Chromatin interaction
ENSG00000168175	Chromatin interaction
ENSG00000106004	Chromatin interaction
ENSG00000105997	Chromatin interaction
ENSG00000106006	Chromatin interaction

Extended variants
information (count: 42 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:42 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1025538	chr7:26482342-27376045	Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
2	nsv538805	chr7:26482342-27376045	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	213 gene(s)	inside rSNPs	diseases
3	nsv1018709	chr7:26990384-27216552	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	140 gene(s)	inside rSNPs	diseases
4	nsv538806	chr7:26990384-27216552	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Genic enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	140 gene(s)	inside rSNPs	diseases
5	nsv887856	chr7:27073731-27297791	Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
6	nsv824038	chr7:27119294-27284522	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
7	nsv887857	chr7:27120689-27229549	Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	176 gene(s)	inside rSNPs	diseases
8	nsv824039	chr7:27121825-27294951	Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
9	nsv824040	chr7:27121870-27295010	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
10	nsv887858	chr7:27127231-27188659	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Enhancers ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	57 gene(s)	inside rSNPs	diseases
11	nsv887860	chr7:27127231-27196069	Weak transcription Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
12	nsv887859	chr7:27127231-27196113	Bivalent Enhancer Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
13	nsv887861	chr7:27127231-27206688	Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
14	nsv887862	chr7:27127231-27217359	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	141 gene(s)	inside rSNPs	diseases
15	nsv887863	chr7:27127231-27243106	Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
16	nsv887864	chr7:27127231-27243962	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
17	nsv887865	chr7:27127231-27247279	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
18	nsv887866	chr7:27127231-27248373	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
19	nsv887867	chr7:27127231-27252246	Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
20	nsv824041	chr7:27128039-27294951	Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	183 gene(s)	inside rSNPs	diseases
21	nsv606463	chr7:27135314-27182245	Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
22	nsv887868	chr7:27135314-27202289	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
23	nsv887869	chr7:27135314-27297791	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	181 gene(s)	inside rSNPs	diseases
24	nsv887871	chr7:27136308-27179814	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
25	nsv887872	chr7:27136308-27181437	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
26	nsv887873	chr7:27136308-27186495	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
27	nsv887874	chr7:27136308-27196069	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
28	nsv1020608	chr7:27139892-27324004	Bivalent Enhancer Active TSS Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
29	nsv538807	chr7:27139892-27324004	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
30	nsv1033316	chr7:27140645-27237951	Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	178 gene(s)	inside rSNPs	diseases
31	nsv606465	chr7:27143757-27229549	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	174 gene(s)	inside rSNPs	diseases
32	nsv606466	chr7:27145024-27197319	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
33	nsv606467	chr7:27145100-27196113	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Weak transcription Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	64 gene(s)	inside rSNPs	diseases
34	nsv887875	chr7:27145100-27243962	Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	179 gene(s)	inside rSNPs	diseases
35	nsv532118	chr7:27146920-27354205	Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	182 gene(s)	inside rSNPs	diseases
36	nsv5674	chr7:27152562-27197341	Bivalent Enhancer Weak transcription Active TSS Flanking Bivalent TSS/Enh Enhancers Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
37	esv3386669	chr7:27168427-27171725	Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases
38	nsv887876	chr7:27168858-27196069	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
39	esv3428881	chr7:27169177-27171225	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases
40	nsv824042	chr7:27169231-27247232	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
41	nsv887877	chr7:27169388-27217359	Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	115 gene(s)	inside rSNPs	diseases
42	esv1824277	chr7:27169934-27176966	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:27167800-27171000	Active TSS	Duodenum Smooth Muscle	Duodenum
2	chr7:27168800-27171400	Active TSS	Fetal Kidney	kidney
3	chr7:27168800-27171800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
4	chr7:27169000-27171200	Active TSS	Aorta	Aorta
5	chr7:27169000-27171400	Active TSS	Right Atrium	heart
6	chr7:27169400-27171000	Active TSS	Psoas Muscle	Psoas
7	chr7:27169400-27171000	Active TSS	HSMMtube	muscle
8	chr7:27169400-27171200	Active TSS	A549	lung
9	chr7:27169600-27171000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr7:27169600-27171000	Active TSS	Rectal Smooth Muscle	rectum
11	chr7:27169600-27171000	Active TSS	Thymus	Thymus
12	chr7:27169600-27171200	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr7:27169800-27171000	Active TSS	Sigmoid Colon	Sigmoid Colon
14	chr7:27169800-27171000	Active TSS	Spleen	Spleen
15	chr7:27169800-27171000	Active TSS	Hela-S3	cervix
16	chr7:27169800-27171000	Active TSS	Osteobl	bone
17	chr7:27169800-27171200	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr7:27170000-27171000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
19	chr7:27170000-27171000	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr7:27170000-27171000	Active TSS	Primary T cells from cord blood	blood
21	chr7:27170000-27171400	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
22	chr7:27170000-27171400	Active TSS	Primary B cells from cord blood	blood
23	chr7:27170200-27171000	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr7:27170200-27171000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
25	chr7:27170200-27171000	Active TSS	Primary T helper naive cells from peripheral blood	blood
26	chr7:27170200-27171000	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr7:27170200-27171000	Bivalent/Poised TSS	Brain Anterior Caudate	brain
28	chr7:27170200-27171000	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
29	chr7:27170200-27171200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
30	chr7:27170200-27171200	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr7:27170200-27171200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
32	chr7:27170200-27171200	Bivalent Enhancer	Fetal Brain Male	brain
33	chr7:27170200-27171200	Bivalent/Poised TSS	Fetal Brain Female	brain
34	chr7:27170200-27171400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
35	chr7:27170400-27171000	Active TSS	Primary T helper memory cells from peripheral blood 2	blood
36	chr7:27170400-27171000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
37	chr7:27170400-27171200	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
38	chr7:27170400-27171400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr7:27170600-27171000	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
40	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
41	chr7:27170600-27171000	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
43	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr7:27170600-27171000	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells short term culture	blood
45	chr7:27170600-27171000	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
46	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
47	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
49	chr7:27170600-27171000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr7:27170600-27171000	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links